Further studies are needed to understand the role of <i>PKP2</i> genetic variation and MVP interaction in arrhythmic risk stratification of and left ventricular involvement in ARVC. This evidence concerns the gene PKP2 and arrhythmogenic right ventricular cardiomyopathy.